A four-group urine risk classifier for predicting outcomes in patients with prostate cancer.

Connell SP, Yazbek-Hanna M, McCarthy F, Hurst R, Webb M, Curley H, Walker H, Mills R, Ball RY, Sanda MG, Pellegrini KL, Patil D, Perry AS, Schalken J, Pandha H, Whitaker H, Dennis N, Stuttle C, Mills IG, Guldvik I, Movember GAP1 Urine Biomarker Consortium, Parker C, Brewer DS, Cooper CS, Clark J

Open source

DOI: 10.1111/bju.14811
Published: 2019 Oct
Container: BJU international
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/bju.14811,
  title = {A four-group urine risk classifier for predicting outcomes in patients with prostate cancer.},
  author = {Connell SP and Yazbek-Hanna M and McCarthy F and Hurst R and Webb M and Curley H and Walker H and Mills R and Ball RY and Sanda MG and Pellegrini KL and Patil D and Perry AS and Schalken J and Pandha H and Whitaker H and Dennis N and Stuttle C and Mills IG and Guldvik I and Movember GAP1 Urine Biomarker Consortium and Parker C and Brewer DS and Cooper CS and Clark J},
  year = {2019},
  journal = {BJU international},
  doi = {10.1111/bju.14811},
  url = {https://doi.org/10.1111/bju.14811}
}

RIS

TY  - JOUR
TI  - A four-group urine risk classifier for predicting outcomes in patients with prostate cancer.
AU  - Connell SP
AU  - Yazbek-Hanna M
AU  - McCarthy F
AU  - Hurst R
AU  - Webb M
AU  - Curley H
AU  - Walker H
AU  - Mills R
AU  - Ball RY
AU  - Sanda MG
AU  - Pellegrini KL
AU  - Patil D
AU  - Perry AS
AU  - Schalken J
AU  - Pandha H
AU  - Whitaker H
AU  - Dennis N
AU  - Stuttle C
AU  - Mills IG
AU  - Guldvik I
AU  - Movember GAP1 Urine Biomarker Consortium
AU  - Parker C
AU  - Brewer DS
AU  - Cooper CS
AU  - Clark J
PY  - 2019
JO  - BJU international
DO  - 10.1111/bju.14811
UR  - https://doi.org/10.1111/bju.14811
ER  -

APA

SP, C., M, Y., F, M., R, H., M, W., H, C., H, W., R, M., RY, B., MG, S., KL, P., D, P., AS, P., J, S., H, P., H, W., N, D., C, S., IG, M., I, G., Consortium, M. G. U. B., C, P., DS, B., CS, C., & J, C. (2019). A four-group urine risk classifier for predicting outcomes in patients with prostate cancer.. BJU international. https://doi.org/10.1111/bju.14811

Source records

pubmed · retrieved 2026-09-26T05:00:19.138Z
europe-pmc · retrieved 2026-09-26T05:00:19.164Z